NCT02214953View on ClinicalTrials.gov

Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2007

Conditions
Healthy
Interventions
DRUG

BI 11634 ER formulation A

DRUG

BI 11634 ER formulation B

DRUG

BI 11634 ER formulation M

DRUG

BI 11634 ER formulation C

DRUG

BI 11634 IR tablet

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY